Highlights of ASH in North America

Save the Date!

Join global hematology leaders at Highlights of ASH in North America, a two-day program offered in multiple locations, to explore and discuss the most influential research presented at the latest ASH annual meeting. Choose from several dates and meeting locations to best meet your schedule. Registration opens October 1, 2025!

Chicago, Illinois | January 9-10, 2026
New York, New York | January 9-10, 2026
Washington D.C. | January 16-17, 2026
Seattle, Washington | January 30-31, 2026

Get email updates

About Highlights of ASH in North America

By attending Highlights of ASH, you will gain a comprehensive understanding of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.

Throughout this meeting, you will be able to:

Blood icon

Explore a program that covers the latest and most influential topics in hematology curated from the premier science presented at the ASH annual meeting.

icon for engage interaction-an avatar looking at the screen

Actively engage in interactive panel discussions with speakers and attend small group lunch sessions with experts in the field.

An icon for a group of experts

Network with speakers, exhibitors, and peers in a close-knit setting.

Community Connection Icon

Connect with a community of individuals who share common goals and hold a mutual appreciation for the scientific advancements.

View Program Information

Program Schedule

The program schedule below is identical for all 2026 Highlights of ASH in North America locations. The following information is preliminary and subject to change.

Close All Open All

11:00 a.m.	Registration and Exhibits Open (Lunch provided)
11:45 p.m.	Welcome and Introductions
12:00 p.m.	*Plasma Cell Disorder Personalization*
	Noura Elsedawy, MBBCh University of Tennessee Health Science Center	New York, NY Washington, DC
	Craig Hofmeister, MD, MPH Emory University	Seattle, WA
	Ruben Niesvizky, MD Weill Cornell Medicine	Chicago, IL
12:45 p.m.	Expanding Access, Enhancing Precision in Hematopoietic Cell Transplantation: Innovations in Graft-versus-Host Disease Prophylaxis, Measurable Residual Disease-Guided Strategies, and Post-Transplant Care
	Alexandra Gomez Arteaga, MD Weill Cornell Medicine, New York Presbyterian Hospital	New York, NY
	Marcos de Lima, MD The Ohio State University	Seattle, WA
	Mark Levis, MD, PhD Johns Hopkins University	Washington, DC
	Mariam Nawas, MD University of Chicago Medical Center	Chicago, IL
1:30 p.m.	*Advances in Pediatric Hematologic Malignancies from Enhanced Risk Stratification to Novel Therapies*
	Rebecca Gardner, MD St. Jude Children’s Research Hospital	Chicago, IL
	Rachel Rau, MD University of Washington	Seattle, WA
	Rayne H. Rouce, MD Baylor College of Medicine	New York, NY Washington, DC
2:15 p.m.	Panel Discussion
2:45 p.m.	Coffee Break and Exhibits Open
3:00 p.m.	Advances in Aggressive Lymphoma in Novel Therapy Era
	Manali Kamdar, MD, MBBS University of Colorado	Seattle, WA
	John Kuruvilla, MD, FRCPC Princess Margaret Cancer Centre	New York, NY
	Selay Lam, MD Western University, London Health Sciences Centre	Chicago, IL
	Craig Moskowitz, MD University of Miami, Sylvester Comprehensive Cancer Center	Washington, DC
3:45 p.m.	*How I Treat Acute Lymphoblastic Leukemia in 2025: Sequencing for Cure in the Era of Targeted and Novel Immune Therapies*
	Emily Curran, MD University of Cincinnati Cancer Center	New York, NY
	Rawan Faramand, MD H. Lee Moffitt Cancer Center	Washington, DC
	John Molina, MD, EdM Taussig Cancer Institute, Cleveland Clinic	Seattle, WA
	Lori Muffly, MD, MS Stanford University	Chicago, IL
4:30 p.m.	*Updates in Management of Indolent Lymphoma and Chronic Lymphocytic Leukemia*
	Jia Ruan, MD, PhD Weill Cornell Medicine	New York, NY
	Mazyar Shadman, MD, MPH Fred Hutchinson Cancer Center, University of Washington	Chicago, IL Seattle, WA
	Tanya Siddiqi, MD City of Hope Orange County	Washington, DC
5:15 p.m.	Panel Discussion
5:45 p.m.	Highlights of ASH Day 1 Program Adjournment

7:00 a.m.	Registration and Exhibits Open (Breakfast provided)
7:45 a.m.	Welcome and Introductions
8:00 a.m.	Emerging Frontiers in Bleeding Disorder Care: Advances in Therapies and Clinical Practice
	Tyler W. Buckner, MD, MSc University of Colorado School of Medicine	Washington, DC
	Peter H. Cygan, MD Penn State Health Milton S. Hershey Medical Center	New York, NY
	Kristina Maria Haley, DO Oregon Health & Science University	Seattle, WA
	Lynn Malec, MD, MSc Versiti Blood Research Institute, Medical College of Wisconsin	Chicago, IL
8:45 a.m.	Turning the Tide in Thrombosis: Breakthrough Mechanisms, Diagnostics, and Therapies
	Joana M. Mack, MD Arkansas Children's Hospital, University of Arkansas for Medical Sciences	Washington, DC
	Anna L. Parks, MD University of Utah	Seattle, WA
	Rachel P. Rosovsky, MD, MPH Massachusetts General Hospital, Harvard Medical School	New York, NY
	Robert Stern, MD, EdM Brigham and Women’s Hospital	Chicago, IL
9:30 a.m.	*Hematology Through a Gender Lens: Evolving Insights into Unique and Underrecognized Challenges in Hematology*
	Imo J. Akpan, MD Columbia University Irving Medical Center	New York, NY
	Allison P. Wheeler, MD, MSCI University of Washington	Chicago, IL Seattle, WA
	Meera Chitlur, MD Central Michigan University, Children's Hospital of Michigan	Washington, DC
10:15 a.m.	Panel Discussion
10:45 a.m.	Coffee Break and Exhibits Open
11:00 a.m.	Progress and Promise: Practice Insights into Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Chronic Myeloid Leukemia from the Amercian Society of Hematology 2025
	Uma Borate, MD, MS The Ohio State University	Chicago, IL
	Akriti Gupta Jain, MD, FACP Cleveland Clinic	New York, NY Seattle, WA
	Brandi Reeves, MD University of North Carolina at Chapel Hill	Washington, DC
11:45 a.m.	The Future is Now: Advances in Acute Myeloid Leukemia
	Jessica K. Altman, MD Northwestern Medicine	New York, NY
	David Sanford, MD UBC-BC Cancer Agency, Vancouver Coastal Health	Seattle, WA
	Caner Saygin, MD University of Chicago	Chicago, IL
	Eunice S. Wang, MD Roswell Park Comprehensive Cancer Center	Washington, DC
12:30 p.m.	Panel Discussion
1:00 p.m.	Lunch with the Experts (All Speakers and Attendees)
2:15 p.m.	Updates in Hemoglobinopathy Evaluation and Management
	Oyebimpe O. Adesina, MD, MS University of California Davis School of Medicine	Seattle, WA
	Payal Desai, MD Levine Cancer Institute, Atrium Health, Wake Forest University	New York, NY
	India Sisler, MD Children’s Hospital of Richmond at VCU	Washington, DC
	Madhav Vissa, MD UCSF Benioff Children’s Hospital	Chicago, IL
3:00 p.m.	*Autoimmune Cytopenias: Targeted, Tailored, Transformed*
	Juliana P. Botero, MD, MS Mayo Clinic	New York, NY
	Cyrus C. Hsia, MD, FRCPC Western University, London Health Sciences Center	Washington, DC
	Caroline Piatek, MD University of Southern California	Seattle, WA
	Senthil Sukumar, MD, MS Baylor College of Medicine	Chicago, IL
3:45 p.m.	*Artificial Intelligence & Informatics in Hematology: Driving Practice Improvement and Patient-Centered Care*
	Benjamin Chin-Yee, MD, MA, FRCPC Western University	Chicago, IL
	Barbara Lam, MD Fred Hutchinson Cancer Center, University of Washington	Seattle, WA
	Ang Li, MD, MS Baylor College of Medicine	New York, NY
	Rushad Patell, MD Beth Isreal Deaconess Medical Center	Washington, DC
4:30 p.m.	Panel Discussion
5:00 p.m.	Closing Remarks and Adjournment

Acknowledgements

Thank you to our esteemed committee of experts dedicated to advancing the development of this meeting, our State Society Partners, and our company partners for providing educational grants in support of the 2026 Highlights of ASH in North America.

Jia Ruan, MD, PhD, Chair, Weill Cornell Medicine 
Tyler Buckner, MD, MSc, University of Colorado Denver 
Payal C. Desai, MD, Atrium Health
Cyrus C. Hsia, MD, BSc, FRCPC, Western University
Manali Kamdar, MD, University of Colorado
Ang Li, MD, MS, Baylor College of Medicine
John C. Molina, MD, MEd, Cleveland Clinic
Ruben Niesvizky, MD, Weill Cornell Medicine
Rachel P. Rosovsky, MD, Harvard Medical School
Rayne H. Rouce, MD, Baylor College of Medicine
Eric Tse, MBBS, PhD, Hong Kong University

The American Society of Hematology would like to acknowledge the following companies for the educational grants provided in support of the 2026 Highlights of ASH® in North America.

AstraZeneca

We also wish to recognize the commitment of our State Societies in their support of the Highlights of ASH in North America meeting.

Gasco Logo Wide

Highlights of ASH in North America

Save the Date!

About Highlights of ASH in North America

Program Schedule

Friday

Saturday

Acknowledgements

Explore the Meeting